Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway-Reference-Cited by-同舟云学术

Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway

Published:2021-07-18 Issue:3 Volume:24 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Feng Xiaoyan¹,Ma Weiwei²,Zhu Jie¹,Jiao Wei¹,Wang Yuhai¹

Affiliation:

1. Department of Neurosurgery, Wuxi Clinical College of Anhui Medical University, 904th Hospital of Joint Logistic Support Force of PLA, Wuxi, Jiangsu 214044, P.R. China

2. Clinical Medicine Five‑Year Program, 11 Class, 2019 Grade, Wannan Medical College, Wuhu, Jiangsu 241002, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Intravenous Anesthetics for Neuro: Protection or Toxicity?;Neuroscience Bulletin;2024-08-17

2. Association of early dexmedetomidine exposure with brain injury biomarker levels following moderate - severe traumatic brain injury: A TRACK-TBI study;Journal of Clinical Neuroscience;2024-08

3. Dexmedetomidine facilitates autophagic flux to promote liver regeneration by suppressing GSK3β activity in mouse partial hepatectomy;Biomedicine & Pharmacotherapy;2024-08

4. Dexmedetomidine ameliorates x-ray-induced myocardial injury via alleviating cardiomyocyte apoptosis and autophagy;BMC Cardiovascular Disorders;2024-06-26

5. The Interplay between Ferroptosis and Neuroinflammation in Central Neurological Disorders;Antioxidants;2024-03-26